GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (XTER:COP) » Definitions » 3-Year FCF Growth Rate

CompuGroup Medical SE KgaA (XTER:COP) 3-Year FCF Growth Rate : 5.00% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is CompuGroup Medical SE KgaA 3-Year FCF Growth Rate?

CompuGroup Medical SE KgaA's Free Cash Flow per Share for the three months ended in Dec. 2023 was €0.27.

During the past 12 months, CompuGroup Medical SE KgaA's average Free Cash Flow per Share Growth Rate was 62.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 5.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -0.50% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 19.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of CompuGroup Medical SE KgaA was 84.80% per year. The lowest was -33.40% per year. And the median was 10.75% per year.


Competitive Comparison of CompuGroup Medical SE KgaA's 3-Year FCF Growth Rate

For the Health Information Services subindustry, CompuGroup Medical SE KgaA's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CompuGroup Medical SE KgaA's 3-Year FCF Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CompuGroup Medical SE KgaA's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where CompuGroup Medical SE KgaA's 3-Year FCF Growth Rate falls into.



CompuGroup Medical SE KgaA 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


CompuGroup Medical SE KgaA  (XTER:COP) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


CompuGroup Medical SE KgaA 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


CompuGroup Medical SE KgaA (XTER:COP) Business Description

Traded in Other Exchanges
Address
Maria Trost 21, Koblenz, DEU, 56070
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through four segments: Ambulatory information systems, Pharmacy information systems, Hospital information systems, and Consumer and Health Management Information Systems. The Ambulatory information systems segment contributes to the majority of revenue and provides practice management software and electronic medical record management. Pharmacy information systems provide clinical, administrative, and financial software for retail pharmacies. The Hospital information systems segment sells its solutions to in-patient centers. Consumer and Health Management Information Systems offers networking service connect providers and other market participants.
Executives
Michael Rauch Managing director of the general partner of the issuer
Emanuele Mugnani Managing director of the general partner of the issuer
Frank Gotthardt Chairman of Administrative Board of CompuGroup Medical Management SE
Prof. (apl.) Dr. Med Daniel Gotthardt Member of the Administrative Board of CompuGroup Medical Management SE
Hannes Reichl Managing director of the general partner of the issuer
Dr. Eckart Pech Managing director of the general partner of the issuer
Dr. Dirk Wössner CEO, Managing director of the general partner of the issuer
Dr. Ralph Körfgen Managing director of the general partner of the issuer

CompuGroup Medical SE KgaA (XTER:COP) Headlines

From GuruFocus

ConocoPhillips Analyst & Investor Meeting Transcript

By GuruFocus Research 01-22-2024

ConocoPhillips Market Update Conference Call Transcript

By GuruFocus Research 01-22-2024

Q2 2022 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2019 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2021 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2020 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2019 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

ConocoPhillips Annual Shareholders Meeting Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024